DAILIES™ AquaComfort™ PLUS (US-DAP-2400005)
1. Wolffsohn J, Hunt 0, Chowdhury A. Objective clinical performance of 'comfort enhanced ' daily disposable soft contact lenses. Cont Lens Anterior Eye. 2010;33(2):88 -92. P<0.05.
2. Marx S, Muller C, Sickenberger W. Subjective pre -lens tear film stability of daily disposable contact lenses using ring mire projection. Cont Lens Anterior Eye. 2015;38:eS.
See production information for complete wear, care and safety information. 

DAILIES™ AquaComfort™ PLUS Toric (US-DAT-2400001)

* Based on DAILIES® AquaComfort PLUS® sphere contact lenses.
1. PRECISION CURVE: Outstanding stability and clear vision. CLM-DAT-GLB-0003. Alcon data on file, 2019. Available on request
2. Alcon data on file, 2019.
3. Wolffsohn JS, Hunt OA, Chowdhury A. Objective clinical performance of ‘comfort-enhanced’ daily disposable soft contact lenses. Cont Lens Anterior Eye. 2010:33(2):88-92
4. Alcon data on file, 2010, 2013. P<0.05.
See production information for complete wear, care and safety information.

DAILIES™ AquaComfort™ PLUS Multifocal (US-DAM-2400001)
^ Based on DAILIES™ AquaComfort™ PLUS sphere contact lenses. 

1. Pruitt J, et al. Triple-action moisturisers for increased comfort in daily disposable lenses. Optician. 2007;11:27-28.
2. Lemp J, Kern J. Alcon multifocal contact lenses for presbyopia correction. Paper presented at the Canadian Association of Optometrists Congress; June 28-30, 2017; Ottawa, ON. 
3. Alcon Data on File, 2016
See production information for complete wear, care and safety information.

PRECISION1™ (US-PR1-2400041)
*Based on in vitro measurements of unworn lenses.
1. Alcon data on file, 2018
2. Fogt J, Patton K. Long day wear experience with water surface daily disposable contact lenses. Clin Optom. 2022(14):93-99.
See product instructions for complete wear, care and safety information.

PRECISION1™ for Astigmatism (US-PRA-2400004)
*Based on 98.7% of eyes with lens oscillation with blink of ≤5° while wearing PRECISION1™ for Astigmatism contact lenses
**Based on in vitro measurements of unworn lenses.
1.  Hines B, et. al. Clinical subjective performance of two daily disposable toric soft contact lenses. Poster presented at: American Optometric Association, Chicago. June 15-18, 2022.
2. Alcon data on file, 2020.
3. Alcon data on file, 2021.
See production information for complete wear, care and safety information.

DAILIES TOTAL1™ (US-DT1-2400064)
 *Based on in vitro measurements of unworn lenses.
1. Thekveli S, Qui Y, Kapoor Y, et al. Structure-property relationship of delefilcon A lenses. Contact Lens Anterior Eye. 2012;35(Suppl 1):e14. 
2. Angelini TE, Nixon RM, Dunn AC, et al. Viscoelasticity and mesh-size at the surface of hydrogels characterized with microrheology. Invest Ophthalmol Vis Sci. 2013;54:E-abstract 500.
3. Dailies Total1 Monadic Claim Trial support. Alcon Data on file, 2024. Study Number: CLU484-P003
See product instructions for complete wear, care and safety information

DAILIES TOTAL1™ for Astigmatism (US-DTA-2400014)
*Based on in vitro measurements of unworn lenses.
1. Alcon data on file, 2021.
2. In a study where n=47; Alcon data on file, 2020.
See production information for complete wear, care and safety information


DAILIES TOTAL1™ Multifocal (US-DTM-2400007)
*Internal estimates based on internal and third-party data.
**With two lenses or less, at the initial fitting visit
***Based on in vitro measurements of unworn lenses.
1. Alcon data on file, 2016. 
2. Lemp J, Kern J. Alcon multifocal contact lenses for presbyopia correction. Paper presented at the Canadian Association of Optometrists Congress; June 28-30, 2017; Ottawa, ON. 
3. Merchea M, Evans D, Kannarr S, et al. Patient and ECP Satisfaction in the United States with a Novel Water Gradient Daily Disposable Multifocal Contact Lens. Presented at the American Optometric Association Annual Meeting, June 20-24, 2018. Denver, CO. 
4. Alcon data on file, 2017. 
5. Alcon data on file, 2013. 
6. Alcon data on file, 2023. 
7. Bauman E, Lemp J, Kern J. Material effect on multifocal contact lens fitting of lenses of the same optical design with the same fitting guide. Poster presented at the British Contact Lens Association (BCLA) Clinical Conference and Exhibition, June 9-11, 2017. Liverpool, UK. 
8. Merchea M, Evans D, Kannarr S, et al. Assessing a modified fitting approach for improved multifocal contact lens fitting success. Presented at the American 
Optometric Association Annual Meeting, June 21-25, 2018. Denver, CO.
See production information for complete wear, care and safety information.

TOTAL30™ (US-T30-2400169)
†Based on in vitro measurements of unworn lenses. 
*There is no demonstrated clinical benefit to a 34% reduction in blue-violet HEV light at wavelengths below 450 nm. BVL testing done on lehfilcon A sphere lenses. 
** UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. The patient should continue to use UV-absorbing eyewear as directed.

1 . In a clinical study wherein patients (n=66) used CLEAR CARE solution for nightly cleaning, disinfecting, and storing; Alcon data on file, 2021.
2.  Laboratory assessment of ultraviolet and visible light transmission properties of lehfilcon A contact lenses using spectrophotometer; Alcon data on file, 2020.
3. ISO 18369-2:2017 Ophthalmic optics — Contact lenses Part 2: Tolerances.
4. ANSI Z80.20-2016 ophthalmic contact lens UV transmittance.
See production information for complete wear, care and safety information

TOTAL30™ for Astigmatism (US-T3A-2400030)
†Based on in vitro measurements of unworn lenses.
* UV Absorbing contact lenses are not substitutes for protective UV absorbing eyewear, such as UV absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. The patient should continue to use UV absorbing eyewear as directed.
**There is no demonstrated clinical benefit to reduction in blue-violet light at wavelengths below 450 nm. BVL testing done on lehfilcon A sphere lenses.

1.  Alcon data on file, 2021.
2.  In a study where n=69, Alcon data on file,  2021.
3. Laboratory assessment of ultraviolet and visible light transmission properties of lehfilcon A sphere contact lenses using spectrophotometer; Alcon data on file, 2020.
4. ISO 18369-2:2017 Ophthalmic optics — Contact lenses Part 2: Tolerances.
5. ANSI Z80.20-2016 ophthalmic contact lens UV transmittance.
See production information for complete wear, care and safety information

TOTAL30™ Multifocal (US-T3M-2400026)
†Based on in vitro measurements of unworn lenses.

1. Alcon data on file, 2022. 
2. In a clinical study wherein patients used CLEAR CARE solution for nightly cleaning, disinfecting, and  storing; Alcon data on file, 2021.
See production information for complete wear, care and safety information

AIR OPTIX™ plus HydraGlyde™ (US-AHG-2400002)
1. Eiden SB, Davis RL, Bergenske PD.  Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective measures of health, comfort, and vision.  Eye & Contact Lens.  2013;39(4):290-294.
2. Based on a 30-day clinical study of 75 habitual lotrafilcon B lens wearers.  Alcon data on file, 2017. Available on request.
3. Lemp j, Kern J.  A comparison of real time and recall comfort assessments.  Optom Vis Sci. 2016;93:Eabstract 165256.

Important information for AIR OPTIX® plus HydraGlyde® (lotrafilcon B) contact lenses: For daily wear or extended wear up to 6 nights for near/far-sightedness. Risk of serious eye problems (i.e., corneal ulcer) is greater for extended wear. In rare cases, loss of vision may result. Side effects like discomfort, mild burning or stinging may occur.
See product instructions for complete wear, care and safety information.

AIR OPTIX™ plus HydraGlyde™ for Astigmatism (US-AHA-2400002)
1. Eiden SB, Davis RL, Bergenske PD. Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective and subjective measures of health, comfort, and vision. Eye & Contact Lens. 2013;39(4):290-294.
2. Based on a 30-day clinical study of 75 habitual lotrafilcon B lens wearers; Alcon data on file, 2017.
3. Lemp J, Kern J. A comparison of real time and recall comfort assessments. Optom Vis Sci. 2016;93:Eabstract 165256.

Important information for AIR OPTIX® plus HydraGlyde® (lotrafilcon B) contact lenses: For daily wear or extended wear up to 6 nights for near/far-sightedness. Risk of serious eye problems (i.e., corneal ulcer) is greater for extended wear. In rare cases, loss of vision may result. Side effects like discomfort, mild burning or stinging may occur.
See production information for complete wear, care and safety information.


AIR OPTIX™ plus HydraGlyde™ Multifocal (US-AHM-2400003)
1.  In vitro study over 16 hours, to measure wetting substantivity. Alcon data on file, 2015. 
2. Muya L, Lemp J, Kern JR, Sentell KB, Lane J, Perry SS.  Impact of packaging saline wetting agents on wetting substantivity and lubricity.  Invest Opthalmol Vis Sci.2016; 57:E-abstract 1463.

Important information for AIR OPTIX® plus HydraGlyde® (lotrafilcon B) contact lenses: For daily wear or extended wear up to 6 nights for near/far-sightedness. Risk of serious eye problems (i.e., corneal ulcer) is greater for extended wear. In rare cases, loss of vision may result. Side effects like discomfort, mild burning or stinging may occur.
See product instructions for complete wear, care and safety information.

AIR OPTIX™ NIGHT&DAY™ AQUA (US-AON-2400003)
†Extended wear for up to 30 continuous nights, as prescribed by an eye care professional.
*Dk/t = 175 @ -3.00D. Other factors may impact eye health.

AIR OPTIX™ NIGHT & DAY™ AQUA package insert.
Based on the ratio of lens oxygen transmissibility. REF-00022. Alcon data on file, 2009, 2010. Available on request.

Important information for AIR OPTIX® NIGHT & DAY® AQUA (lotrafilcon A) contact lenses: Indicated for vision correction for daily wear (worn only while awake) or extended wear (worn while awake and asleep) for up to 30 nights. Relevant Warnings: A corneal ulcer may develop rapidly and cause eye pain, redness or blurry vision as it progresses. If left untreated, a scar, and in rare cases loss of vision, may result. The risk of serious problems is greater for extended wear vs. daily wear and smoking increases this risk. A one-year post-market study found 0.18% (18 out of 10,000) of wearers developed a severe corneal infection, with 0.04% (4 out of 10,000) of wearers experiencing a permanent reduction in vision by two or more rows of letters on an eye chart. Relevant Precautions: Not everyone can wear for 30 nights. Approximately 80% of wearers can wear the lenses for extended wear. About two-thirds of wearers achieve the full 30 nights continuous wear. Side Effects: In clinical trials, approximately 3-5% of wearers experience at least one episode of infiltrative keratitis, a localized inflammation of the cornea which may be accompanied by mild to severe pain and may require the use of antibiotic eye drops for up to one week. Other less serious side effects were conjunctivitis, lid irritation or lens discomfort including dryness, mild burning or stinging. Contraindications: Contact lenses should not be worn if you have: eye infection or inflammation (redness and/or swelling); eye disease, injury or dryness that interferes with contact lens wear; systemic disease that may be affected by or impact lens wear; certain allergic conditions or using certain medications (ex. some eye medications). Additional Information: Lenses should be replaced every month. If removed before then, lenses should be cleaned and disinfected before wearing again. Always follow the eye care professional’s recommended lens wear, care and replacement schedule. Consult package insert for complete information, available without charge by calling (800) 241-5999 or go to myalcon.com
See production information for complete wear, care and safety information.

AIR OPTIX™ COLORS (US-AOC-2400010)
*Dk/t = 138 @ -3.00D. Other factors may impact eye health

1. Eiden SB, Davis RL, Bergenske PD. Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective and subjective measures of health, comfort and vision. Eye Contact Lens. 2013;39(4):290-294. 
2. Lemp J, Kern J. A comparison of real time and recall comfort assessments. Optom Vis Sci. 2016;93E-abstract 165256. 
3. Alcon data on file, 2014. 
4. Dillehay S, Miller M. Perfomance of Lotrafilcon B silicone Hydrogel Contact lenses in Experienced Low-Dk/t Daily Lens Wearers. Eye & Contact Lens 2007;33(6):272-277. 
5. Luensmann D, Yu M, Yang J, Srinivasan S, Jones L. Impact of cosmetics on the physical dimension and optical performance of silicone hydrogel contact lenses. Eye Contact Lens. 2015 Jul;41(4):218-227.
See production information for complete wear, care and safety information

Important information for AIR OPTIX® COLORS (lotrafilcon B) contact lenses: For daily wear only for near/far-sightedness. Contact lenses, even if worn for cosmetic reasons, are prescription medical devices that must only be worn under the prescription, direction and supervision of an eye care professional. Serious eye health problems may occur as a result of sharing contact lenses. Although rare, serious eye problems can develop while wearing contact lenses. Side effects like discomfort, mild burning or stinging may occur. To help avoid these problems, patients must follow the wear and replacement schedule and the lens care instructions provided by their eye doctor.

PRECISION7® for Astigmatism (US-P7A-2400030)

1.In a 28-day prospective clinical study; n=92; Alcon data on file, 2023.
2. In a 2-week prospective clinical study in the US; n=181; CLEAR CARE® Cleaning & Disinfecting Solution used for cleaning and disinfection; Alcon data on file, 2023. (p=0.0353)
3. Zheng Y, Dou J, Wang Y, et al. Sustained release of a polymeric wetting agent from a silicone-hydrogel contact lens material. ACS Omega. 2022;7(33):29223-29230. doi:10,1021/acsomega.2c03310.
4. Alcon data on file, 2023.
5. Phan CM, Chan VWY, Drolle E, et al. Evaluating the in vitro wettability and coefficient of friction of a novel and contemporary reusable silicone hydrogel contact lens materials using an in vitro blink model. Cont Lens Anterior Eye. 2024; Volume 47(2):1-11.

Important information for PRECISION7® for Astigmatism (serafilcon A) contact lenses: For daily wear or extended wear up to 6 nights for near/far-sightedness. Risk of serious eye problems (i.e., corneal ulcer) is greater for extended wear. In rare cases, loss of vision may result. Side effects like discomfort, mild burning or stinging may occur. See product instructions for complete wear, care and safety information.

PRECISION7® (US-PR7-2400280)

1. In a 2-week prospective clinical study in the US; n=181; CLEAR CARE® Cleaning & Disinfecting Solution used for cleaning and disinfection; Alcon data on file, 2023. (p=0.0353)
2. Zheng Y, Dou J, Wang Y, et al. Sustained release of a polymeric wetting agent from a silicone-hydrogel contact lens material. ACS Omega. 2022;7(33):29223-29230. doi:10,1021/acsomega.2c03310.
3. Alcon data on file, 2023.
4. Phan CM, Chan VWY, Drolle E, et al. Evaluating the in vitro wettability and coefficient of friction of a novel and contemporary reusable silicone hydrogel contact lens materials using an in vitro blink model. Cont Lens Anterior Eye. 2024; Volume 47(2):1-11.

Important information for PRECISION7® (serafilcon A) contact lenses: For daily wear or extended wear up to 6 nights for near/far-sightedness. Risk of serious eye problems (i.e., corneal ulcer) is greater for extended wear. In rare cases, loss of vision may result. Side effects like discomfort, mild burning or stinging may occur.

See product instructions for complete wear, care and safety information.

OPTI-FREE® Puremoist® (US-OFM-2400036)

OPTI-FREE® REPLENISH® Contact Lens Rewetting Drops (US-OFR-2400005)

OPTI-FREE® PUREMOIST® Contact Lens Rewetting Drops (US-OFM-2400038)

OPTIFREE® Replenish® Contact Lens Solution (US-OFR-2400004)

Systane® COMPLETE (US-SYC-2400023)
* vs Systane Balance
**Based on internal assessment and patient segmentation
***Not a rewetting drop 

1.Silverstein S, Yeu E, Tauber J, et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167-3177. 
See instructions for use, precautions, warnings and contraindications

Systane® COMPLETE PRESERVATIVE-FREE (US-SYX-2400090)
* Also available in a preserved version 
** Based on internal assessment and patient segmentation 
***Not a rewetting solution
^ Please refer to instructions for use

1.Silverstein S. et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clinical Ophthalmology 2020:14 3167–3177
See instructions for use, precautions, warnings and contraindications

Systane® ULTRA PRESERVATIVE-FREE (US-SYZ-2400002)
*Also available in a preserved version
**Based on internal assessment and patient segmentation
***Please refer to instructions for use

1.Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353. .
2.Christensen MT, Martin AE, Bloomenstein M. A comparison of efficacy between Systane Ultra and Optive lubricant eye drops when tested with dry eye patients. Optometry. 2009;80(6):315. 
See instructions for use, precautions, warnings and contraindications

Systane® HYDRATION PRESERVATIVE-FREE (US-SYY-2400002)
**Also available in a preserved version
***Based on internal assessment and patient segmentation
****In mouse cornea model
*****Please refer to instructions for use

1.Carlson E, Kao WWY, Ogundele A. Impact of hyaluronic acid-containing artificial tear products on reepithelialization in an in vivo corneal wound model. J Ocul Pharmacol Ther. 2018;34(4):360-364. doi:10.1089/jop.2017.0080
2.Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium. J. Ocul. Pharmacol. Ther. 2015;31(8):491-497. 
3.Davitt, WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353. 
4.Rolando M, Autori S, Badino F, Barabino S. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther. 2009;25(3):271-278. 
See instructions for use, precautions, warnings and contraindications.

Systane® ULTRA (US-SYU-2400001)
*Based on internal assessment and patient segmentation
**Please refer to instructions for use

1.Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353. .
2.Christensen MT, Martin AE, Bloomenstein M. A comparison of efficacy between Systane Ultra and Optive lubricant eye drops when tested with dry eye patients. Optometry. 2009;80(6):315. 
See instructions for use, precautions, warnings and contraindications.

Systane® HYDRATION (US-SYH-2400001)
* In vitro data
**Based on internal assessment and patient segmentation
***Please refer to instructions for use

1.Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium. J. Ocul. Pharmacol. Ther. 2015;31(8):491-497. 
2.Davitt, WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353. 
3.Rolando M, Autori S, Badino F, Barabino S. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther. 2009;25(3):271-278. 
See instructions for use, precautions, warnings and contraindications.

Systane® BALANCE (US-SYB-2400001)
*Based on internal assessment and patient segmentation

1.Benelli U. Systane lubricant eye drops in the management of ocular dryness. Clin Ophthalmol. 2011:5;783-790.
2.Korb DR, Blackie CA, Meadows DL, Christensen M, Tudor M. Evaluation of extended tear stability by two emulsion based artificial tears. Poster presented at: 6th International Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance; September 22-25, 2010; Florence, Italy. 
See instructions for use, precautions, warnings and contraindications


Systane® GEL DROPS (US-SGD-2400001)
*Based on internal assessment and patient segmentation
**Please refer to instructions for use

1. Cohen S, et al. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose. Clin Ophtalmology. 2014;8:157-164.
2.Christensen M, Martin A, Meadows D. An evaluation of the efficacy and patient acceptance of a new lubricant eye gel. The American Academy of Optometry Annual Meeting; 2011; E-Abstract 115013.
See instructions for use, precautions, warnings and contraindications.

SYSTANE® Night Gel (US-SYG-2400001)

SYSTANE® NIGHTTIME Ointment (US-SYN-2400001)

CLEAR CARE® Contact Lens Solution (US-CCS-2400003)

CLEAR CARE® PLUS Contact Lens Solution (US-CCP-2400016)

SYSTANE® ZADITOR® Antihistamine Eye Drops (US-ZAD-2400002)

Systane® Original Preservative Free (US-SYP-2400001)

GENTEAL® Tears SEVERE EYE OINTMENT (US-GNT-2400006)

SYSTANE® Original (US-SYD-2400003)

Pataday® Once Daily Relief EXTRA STRENGTH (US-PTD-2400147)

Pataday® Once Daily (US-PTD-2400146)

Pataday® Twice Daily (US-PTD-2400145)

NAPHCON A® (US-NPA-2400001)

GenTeal® Tears Moderate Liquid Drops (US-GMO-2400001)

GenTeal® Tears Liquid Drops Preservative Free (US-GPF-2400001)

GenTeal® Tears Mild Liquid Drops (US-GMD-2400001)

GenTeal Tears Gel (US-GLE-2400001)